Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Salvadora persica is a small evergreen tree or shrub native to the Middle East, Africa, and India. It is best known for its use as a natural toothbrush (miswak), recommended by the World Health Organization for oral hygiene. The plant contains various bioactive compounds including flavonoids, alkaloids (such as salvadorine), saponins, tannins, sterols/terpenes (e.g., β-sitosterol), glycosides, organic sulfur compounds and minerals like fluoride and silica. Salvadora persica exhibits multiple pharmacological activities such as antibacterial (notably against oral pathogens), antiviral (including activity against COVID-19 proteases in vitro), antifungal (notably against Candida species), anti-inflammatory (due to phenolic compounds and enzymes like catalase and peroxidase), antioxidant (protecting cells from oxidative stress via polyphenol oxidase enzymes), analgesic effects comparable or superior to aspirin in animal studies due to sterols/flavonoids content; mild laxative/digestive effects attributed to anthraquinones; anxiolytic and antidepressant-like effects demonstrated in animal models. Its primary applications are in dental health but it also shows promise for broader therapeutic uses[1][2][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on salvadora persica.